• Home
  • Contact

WHO resumes hydroxychloroquine and chloroquine trials

Biotech Today — June 5, 2020 in News 4 Likes 212 Views Share TwitterTweet on Twitter FacebookShare on Facebook Google+Google+ PinterestPinterest

WHO has decided to resume hydroxychloroquine and chloroquine (HCQ/CQ) trails after Indian scientists have questioned its earlier decision.

The post WHO resumes hydroxychloroquine and chloroquine trials appeared first on BioTech Times.

Source

chloroquine CSIR Drugs HCQ hydroxychloroquine IGIB News WHO

About the Author: Biotech Today

You might like

Zealand Pharma’s drug for rare metabolic disease smashes phase III

23 hours ago 0 Likes 4

Evotec, Sernova in partnership to develop beta cell diabetes therapy

2 days ago 0 Likes 3

F2G enlists Shionogi to bring antifungal treatment to Europe and Asia

2 days ago 0 Likes 4

Meet the Future Makers of Labiotech

2 days ago 0 Likes 3

US Giant Apollo Bags Billion-Euro Partnership with Sofinnova

4 days ago 1 Likes 7

Optimizing Bioproduction Using Transient Expression Systems

4 days ago 0 Likes 5
[cm_ad_changer group_id="3"]

Recent Posts

  • Zealand Pharma’s drug for rare metabolic disease smashes phase III
  • Evotec, Sernova in partnership to develop beta cell diabetes therapy
  • F2G enlists Shionogi to bring antifungal treatment to Europe and Asia
  • Meet the Future Makers of Labiotech
  • US Giant Apollo Bags Billion-Euro Partnership with Sofinnova
  • Optimizing Bioproduction Using Transient Expression Systems
  • Valneva’s Covid-19 Vaccine Contract in Dire Straits as EU Approval Lags
  • CRISPR Can Help The Switch To Sustainable Cosmetics
  • Domain Therapeutics Bags €39M to Block GPCRs in Cancer Immunotherapy
  • The Top European Biotech Investments in April 2022
[cm_ad_changer group_id="4"]
[cm_ad_changer group_id="5"]
© 2020 biotechTODAY - Designed by Legendary Group